IFN-γ-producing CD4+ T Cells Promote Experimental Cerebral Malaria by Modulating CD8+ T Cell Accumulation Within the Brain
Overview
Authors
Affiliations
It is well established that IFN-γ is required for the development of experimental cerebral malaria (ECM) during Plasmodium berghei ANKA infection of C57BL/6 mice. However, the temporal and tissue-specific cellular sources of IFN-γ during P. berghei ANKA infection have not been investigated, and it is not known whether IFN-γ production by a single cell type in isolation can induce cerebral pathology. In this study, using IFN-γ reporter mice, we show that NK cells dominate the IFN-γ response during the early stages of infection in the brain, but not in the spleen, before being replaced by CD4(+) and CD8(+) T cells. Importantly, we demonstrate that IFN-γ-producing CD4(+) T cells, but not innate or CD8(+) T cells, can promote the development of ECM in normally resistant IFN-γ(-/-) mice infected with P. berghei ANKA. Adoptively transferred wild-type CD4(+) T cells accumulate within the spleen, lung, and brain of IFN-γ(-/-) mice and induce ECM through active IFN-γ secretion, which increases the accumulation of endogenous IFN-γ(-/-) CD8(+) T cells within the brain. Depletion of endogenous IFN-γ(-/-) CD8(+) T cells abrogates the ability of wild-type CD4(+) T cells to promote ECM. Finally, we show that IFN-γ production, specifically by CD4(+) T cells, is sufficient to induce expression of CXCL9 and CXCL10 within the brain, providing a mechanistic basis for the enhanced CD8(+) T cell accumulation. To our knowledge, these observations demonstrate, for the first time, the importance of and pathways by which IFN-γ-producing CD4(+) T cells promote the development of ECM during P. berghei ANKA infection.
Elevated BACE1 and IFNγ+ T Cells in Patients with Cognitive Impairment and the 5xFAD Mouse Model.
Zhan Y, Chen Z, Zheng S, Dai L, Zhang W, Dai Y ACS Chem Neurosci. 2025; 16(3):384-392.
PMID: 39810314 PMC: 11804866. DOI: 10.1021/acschemneuro.4c00565.
Dookie R, Villegas-Mendez A, Cheeseman A, Jones A, Barroso R, Barrett J Infect Immun. 2024; 92(11):e0034524.
PMID: 39324794 PMC: 11556036. DOI: 10.1128/iai.00345-24.
Zheng Y, Cai X, Wang D, Chen X, Wang T, Xie Y BMC Psychiatry. 2024; 24(1):593.
PMID: 39227832 PMC: 11370234. DOI: 10.1186/s12888-024-06054-x.
Asymptomatic Low-Density Plasmodium falciparum Infections: Parasites Under the Host's Immune Radar?.
Prah D, Laryea-Akrong E J Infect Dis. 2024; 229(6):1913-1918.
PMID: 38349649 PMC: 11175676. DOI: 10.1093/infdis/jiad581.
Gaio P, Cramer A, de Melo Oliveira N, Porto S, Kramer L, Nonato Rabelo R Pharmaceuticals (Basel). 2024; 17(1).
PMID: 38256880 PMC: 10821074. DOI: 10.3390/ph17010046.